调查血清C-反应蛋白度与狗中的蛋白尿之间的关联
E Ruane1, M M A Rodgers1, C H Z Hare1
1Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
The Journal of small animal practice
|October 30, 2025
概括
血清C-反应蛋白度和特定疾病与狗的蛋白尿有关. 慢性肠道病变显示蛋白尿的几率降低,而慢性肝炎和胰腺炎显示增加的几率.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 狗的健康 狗的健康
- 生物标志物 生物标志物
背景情况:
- 蛋白尿,损伤的指标,可以受到系统性条件的影响.
- 血清C反应蛋白 (CRP) 是一种炎症标志物.
- 了解CRP,疾病和蛋白尿之间的关联对于狗的健康至关重要.
研究的目的:
- 调查血清C反应蛋白 (CRP) 度,特定的犬病和蛋白尿症之间的关系.
- 为了确定CRP水平和某些疾病是否是狗中蛋白尿的独立预测因子,而没有先前存在的,前或后原因.
主要方法:
- 追溯性研究,包括测量尿蛋白:肌素比率 (UPC) 和血清CRP的狗.
- 已知病理性蛋白尿病因的狗被排除在外.
- 多变量逻辑回归被用来分析蛋白尿,CRP和特定疾病之间的关联.
主要成果:
- 蛋白尿 (UPC>0.2) 在患有慢性肠病症的狗中不太普遍.
- 蛋白尿在患有慢性肝炎的狗中更为普遍,在患有胰腺炎的狗中更为普遍.
- 血清CRP度升高独立地与蛋白尿的几率增加有关 (OR=1.031).
结论:
- 系统性炎症,由升高的CRP表示,可能与狗的蛋白尿有关.
- 慢性肠道病变与蛋白质尿的几率降低有关.
- 需要进一步的研究来确定因果关系,并评估解决潜在疾病对蛋白尿的影响.
相关概念视频
Serum Studies: Renal Function Tests
359
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
359
Nephrotic Syndrome II : Assessment and Medical Management
192
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
192
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
177
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
177
Chronic Kidney Disease III: Interprofessional Care
333
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
333
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
185
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
185


